INS and Hyperglycemia: The possible reason might be ascribed to the pharmacological properties of the α2-adrenoceptor agonists itself, which can cause hyperglycemia by a mechanism that involves the postsynaptic α2-adrenoceptor stimulation of pancreatic beta cells, which inhibits insulin secretion [19].